Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ASCENDIS PHARMA A/S
A/S
Active
CVR 29918791
Tuborg Boulevard 12, 2900
Hellerup
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2006 · 19 years old
662 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
ASCENDIS PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
132M
263M
395M
527M
8M
2021
51M
2022
303M
2023
406M
2024
458M
2025
EBITDA
DKK millions
158M
-58M
-273M
-488M
-703M
-452M
2021
-562M
-24%
2022
-3M
+99%
2023
126M
+4300%
2024
4M
-97%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
7.778
51.174
302.712
405.780
458.266
Staff expenses
-0
-0
-0
—
—
EBITDA
-451.792
-561.814
-3.191
126.134
4.189
Depreciation & amort.
-0
-0
-0
—
—
EBIT
-451.792
-561.814
-3.191
126.134
4.189
Net financials
67.848
-16.003
42.910
48.606
93.970
Profit before tax
-383.944
-577.817
39.719
174.740
98.159
Tax
-367
5.377
3
40
39.692
Net profit
-383.577
-583.194
39.716
174.700
58.467
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.084.921
1.089.738
0
3.145.158
3.437.393
Equity
883.635
263.348
—
2.392.571
2.625.495
Long-term debt
100.930
655.119
0
9.223
26.882
Short-term debt
99.163
163.932
0
743.250
784.403
Total debt
200.093
819.051
0
752.473
811.285
Financial ratios
5-year trend
EBITDA-margin
0.9%
This company
15.8%
Market median
-94% vs market
2021
2025
Soliditetsgrad
76.4%
This company
38.2%
Market median
+100% vs market
2021
2025
Egenkapitalforrentning
2.2%
This company
18.4%
Market median
-88% vs market
2021
2025
Nettoresultatgrad
12.8%
This company
8.1%
Market median
+58% vs market
2021
2025
Aktivomsætning
0.13×
This company
1.12×
Market median
-88% vs market
2021
2025
Gæld/egenkapital
0.31×
This company
0.62×
Market median
+50% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on ASCENDIS PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
